DEA Cannabis Enforcement News 2025: What to Know

DEA cannabis enforcement news in 2025 centers on the agency’s rescheduling hearings, not on a new federal legalization law. Federal cannabis enforcement still targets illicit trafficking, diversion, and conduct that violates the Controlled Substances Act, while state-licensed cannabis remains legal only under state law.

dea cannabis reclassification updates

What is the main DEA cannabis story in 2025?

The formal story is the proposed rule to move marijuana from Schedule I to Schedule III. DEA published the proposal in the Federal Register in May 2024, and the public comment and administrative hearing process carried into 2025. Rescheduling would not legalize cannabis. It would change federal control status and could affect tax treatment and research access, but it would not create a federal commercial cannabis program.

dea marijuana schedule change news

Is DEA raiding state-legal dispensaries in 2025?

There is no broad public record in 2025 of a nationwide DEA campaign against state-licensed dispensaries. That does not mean state law shields a business from federal enforcement. DEA can still investigate cannabis trafficking, diversion, and operations that violate the Controlled Substances Act. In practice, federal resources tend to focus on larger illicit operations, organized trafficking, and cases with violence or diversion, but a state license is not a federal defense.

related article

What does rescheduling mean for enforcement?

Moving cannabis to Schedule III would reduce the gap between federal and state law, but it would not end federal regulation. A Schedule III drug remains controlled. DEA would still have authority over registration, manufacturing, and distribution rules. For dispensaries, the practical effect would depend on the final rule, state rules, and how other federal agencies apply the change. A proposed rule is not a final rule, and 2025 news should be read with that distinction.

What should consumers and operators watch?

• Federal Register notices and DEA hearing orders on the rescheduling docket.
• Any final rule that changes cannabis from Schedule I to Schedule III.
• DOJ enforcement guidance and congressional appropriations language that limits federal enforcement in medical cannabis states.
• State licensing, testing, packaging, and track-and-trace rules, which still govern legal sales.
• Supply chain records that show where cannabis products came from and where they went.

Bottom line

For 2025, DEA cannabis enforcement news is best understood as a rescheduling and enforcement-priorities story. The rescheduling process may reduce federal conflict with state programs, but the Controlled Substances Act still applies. Consumers and dispensary operators should follow official DEA and Federal Register updates instead of treating a proposal as a final change.